Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids
Yan Chen, Thomas G. Pottanat, Robert W. Siegel, et al.
Journal of Lipid Research (2020) Vol. 61, Iss. 8, pp. 1203-1220
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Metabolic-associated fatty liver disease and lipoprotein metabolism
Jöerg Heeren, Ludger Scheja
Molecular Metabolism (2021) Vol. 50, pp. 101238-101238
Open Access | Times Cited: 403
Dysregulated lipid metabolism links NAFLD to cardiovascular disease
Audrey Deprince, Joel T. Haas, Bart Staels
Molecular Metabolism (2020) Vol. 42, pp. 101092-101092
Open Access | Times Cited: 368
Lipoprotein Lipase and Its Regulators: An Unfolding Story
Shuangcheng Alivia Wu, Sander Kersten, Ling Qi
Trends in Endocrinology and Metabolism (2020) Vol. 32, Iss. 1, pp. 48-61
Open Access | Times Cited: 147
Addressing dyslipidemic risk beyond LDL-cholesterol
Alan R. Tall, David G. Thomas, Ainara G. Cabodevilla, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 1
Open Access | Times Cited: 97
Novel and future lipid-modulating therapies for the prevention of cardiovascular disease
Julia Brandts, Kausik K. Ray
Nature Reviews Cardiology (2023) Vol. 20, Iss. 9, pp. 600-616
Closed Access | Times Cited: 59
Advances in Dyslipidaemia Treatments: Focusing on ApoC3 and ANGPTL3 Inhibitors
Brian Tomlinson, Qianyan Wu, Yi-ming Zhong, et al.
Journal of Lipid and Atherosclerosis (2024) Vol. 13, Iss. 1, pp. 2-2
Open Access | Times Cited: 18
Lipoprotein Lipase: Structure, Function, and Genetic Variation
Shehan D. Perera, Jian Wang, Adam D. McIntyre, et al.
Genes (2025) Vol. 16, Iss. 1, pp. 55-55
Open Access | Times Cited: 2
Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC
Hyun-Mi Kim, Da Som Lee, Tae Hyeon An, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4495-4495
Open Access | Times Cited: 100
Role and mechanism of the action of angiopoietin-like protein ANGPTL4 in plasma lipid metabolism
Sander Kersten
Journal of Lipid Research (2021) Vol. 62, pp. 100150-100150
Open Access | Times Cited: 94
Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8
Kelli L. Sylvers-Davie, Brandon S.J. Davies
AJP Endocrinology and Metabolism (2021) Vol. 321, Iss. 4, pp. E493-E508
Open Access | Times Cited: 84
The multi-faces of Angptl8 in health and disease: Novel functions beyond lipoprotein lipase modulation
Mohamed Abu‐Farha, Anindya Ghosh, Irina Al‐Khairi, et al.
Progress in Lipid Research (2020) Vol. 80, pp. 101067-101067
Open Access | Times Cited: 71
An updated ANGPTL3-4-8 model as a mechanism of triglyceride partitioning between fat and oxidative tissues
Ren Zhang, Kezhong Zhang
Progress in Lipid Research (2021) Vol. 85, pp. 101140-101140
Open Access | Times Cited: 66
The Importance of Lipoprotein Lipase Regulation in Atherosclerosis
Anni Kumari, Kristian Kølby Kristensen, Michael Ploug, et al.
Biomedicines (2021) Vol. 9, Iss. 7, pp. 782-782
Open Access | Times Cited: 62
ANGPTL3 as therapeutic target
Sander Kersten
Current Opinion in Lipidology (2021) Vol. 32, Iss. 6, pp. 335-341
Open Access | Times Cited: 58
ApoA5 lowers triglyceride levels via suppression of ANGPTL3/8-mediated LPL inhibition
Yan Chen, Thomas G. Pottanat, Yuejun Zhen, et al.
Journal of Lipid Research (2021) Vol. 62, pp. 100068-100068
Open Access | Times Cited: 57
Updates in Drug Treatment of Severe Hypertriglyceridemia
Ioanna Gouni‐Berthold, Jonas Andersson Schwarz, Heiner K. Berthold
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 10, pp. 701-709
Open Access | Times Cited: 34
Unlocking the mysteries of VLDL: exploring its production, intracellular trafficking, and metabolism as therapeutic targets
Jingfei Chen, Zhenfei Fang, Qin Luo, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
The chylomicron saga: time to focus on postprandial metabolism
Alejandro Gugliucci
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 13
A unified model for regulating lipoprotein lipase activity
Ren Zhang, Kezhong Zhang
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 6, pp. 490-504
Open Access | Times Cited: 11
Dyslipidemia: A Narrative Review on Pharmacotherapy
Lucas Dorneles de Oliveira, Arthur Cicupira Rodrigues de Assis, Viviane Z. Rocha, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 289-289
Open Access | Times Cited: 10
New Therapies for Lowering Triglyceride-Rich Lipoproteins
Robert S. Rosenson, Aleesha Shaik, Wen‐Liang Song
Journal of the American College of Cardiology (2021) Vol. 78, Iss. 18, pp. 1817-1830
Open Access | Times Cited: 47
An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif
Deepa Balasubramaniam, Oliver C. Schroeder, Anna M. Russell, et al.
Journal of Lipid Research (2022) Vol. 63, Iss. 5, pp. 100198-100198
Open Access | Times Cited: 34
Adipose tissue adipokines and lipokines: Functions and regulatory mechanism in skeletal muscle development and homeostasis
Xin Gu, Liyi Wang, Shiqi Liu, et al.
Metabolism (2022) Vol. 139, pp. 155379-155379
Closed Access | Times Cited: 32
Inhibition of the ANGPTL3/8 Complex for the Prevention and Treatment of Atherosclerotic Cardiovascular Disease
Dick C. Chan, Gerald F. Watts
Current Atherosclerosis Reports (2024) Vol. 27, Iss. 1
Closed Access | Times Cited: 7
Xanthohumol, a prenylated chalcone, regulates lipid metabolism by modulating the LXRα/RXR-ANGPTL3-LPL axis in hepatic cell lines and high-fat diet-fed zebrafish models
Wan-Yun Gao, Pei‐Yi Chen, Hao‐Jen Hsu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116598-116598
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top